Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Lear

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Expert Review of Anticancer Therapy|September 17, 2016
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinomaNicholas J Collier, Faisal R Ali, John T Lear
European Journal of Dermatology : EJD|April 12, 2014
Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acidMartina Ulrich, Giovanni Pellacani, Carlos Ferrandiz, et al.
Current Opinion in Oncology|January 19, 2016
Defining locally advanced basal cell carcinoma and integrating smoothened inhibitors into clinical practiceAndre B S Khoo, Faisal R Ali, John T Lear
Expert Review of Clinical Pharmacology|November 17, 2023
Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinomaJohn T Lear, Linda M Morris, Dylan B Ness, et al.
Journal of the American Academy of Dermatology|June 2, 2009
Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinomaSudarshan Ramachandran, Ratna Rajaratnam, Andrew G Smith, et al.
Clinical and Experimental Dermatology|July 17, 2024
Topical sirolimus in dermatology: a systematic reviewUsamah M Afzal, Mohammad Alazemi, Omar Ali, et al.
Plastic and Reconstructive Surgery. Global Open|August 24, 2017
Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive CasesKai Yuen Wong, Kate Fife, John T Lear, et al.
Cancer Treatment Reviews|February 7, 2018
Emerging trends in the treatment of advanced basal cell carcinomaMichael R Migden, Anne Lynn S Chang, Luc Dirix, et al.
Future Oncology (London, England)|September 20, 2016
Managing adverse events associated with vismodegib in the treatment of basal cell carcinomaKate Fife, Robert Herd, Susan Lalondrelle, et al.
Journal of Medical Economics|October 8, 2016
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care settingRadek Wojcik, Julia Lowin, David Vilardell, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Expert Review of Anticancer Therapy|September 17, 2016
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinomaNicholas J Collier, Faisal R Ali, John T Lear
European Journal of Dermatology : EJD|April 12, 2014
Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acidMartina Ulrich, Giovanni Pellacani, Carlos Ferrandiz, et al.
Current Opinion in Oncology|January 19, 2016
Defining locally advanced basal cell carcinoma and integrating smoothened inhibitors into clinical practiceAndre B S Khoo, Faisal R Ali, John T Lear
Expert Review of Clinical Pharmacology|November 17, 2023
Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinomaJohn T Lear, Linda M Morris, Dylan B Ness, et al.
Journal of the American Academy of Dermatology|June 2, 2009
Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinomaSudarshan Ramachandran, Ratna Rajaratnam, Andrew G Smith, et al.
Clinical and Experimental Dermatology|July 17, 2024
Topical sirolimus in dermatology: a systematic reviewUsamah M Afzal, Mohammad Alazemi, Omar Ali, et al.
Plastic and Reconstructive Surgery. Global Open|August 24, 2017
Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive CasesKai Yuen Wong, Kate Fife, John T Lear, et al.
Cancer Treatment Reviews|February 7, 2018
Emerging trends in the treatment of advanced basal cell carcinomaMichael R Migden, Anne Lynn S Chang, Luc Dirix, et al.
Future Oncology (London, England)|September 20, 2016
Managing adverse events associated with vismodegib in the treatment of basal cell carcinomaKate Fife, Robert Herd, Susan Lalondrelle, et al.
Journal of Medical Economics|October 8, 2016
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care settingRadek Wojcik, Julia Lowin, David Vilardell, et al.
Pageof 5